{
    "id": "dbpedia_2585_2",
    "rank": 87,
    "data": {
        "url": "https://link.springer.com/10.1007/978-3-030-67928-6_145-1",
        "read_more_link": "",
        "language": "en",
        "title": "Drug Abuse in Pakistan",
        "top_image": "https://static-content.springer.com/cover/book/978-3-030-67928-6.jpg",
        "meta_img": "https://static-content.springer.com/cover/book/978-3-030-67928-6.jpg",
        "images": [
            "https://link.springer.com/oscar-static/images/darwin/header/img/logo-springerlink-39ee2a28d8.svg",
            "https://media.springernature.com/w72/springer-static/cover-hires/book/978-3-030-67928-6?as=webp",
            "https://media.springernature.com/w92h120/springer-static/cover-hires/book/978-3-030-92392-1?as=webp",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1038%2Fs41593-022-01160-z/MediaObjects/41593_2022_1160_Fig1_HTML.png",
            "https://media.springernature.com/w215h120/springer-static/image/art%3A10.1007%2Fs10519-015-9737-3/MediaObjects/10519_2015_9737_Fig1_HTML.gif",
            "https://link.springer.com/oscar-static/images/logo-springernature-white-19dd4ba190.svg"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Shagufta Jabeen",
            "Uzma Abdullah",
            "Muhammad Sheeraz Ahmad",
            "Muhammad Mobeen Zafar",
            "Julia K. Pinsonneault",
            "Wolfgang Sadee",
            "Ghazala Kaukab Raja",
            "Muhammad Sheeraz",
            "Muhammad Mobeen",
            "Julia K"
        ],
        "publish_date": "2022-08-12T00:00:00",
        "summary": "",
        "meta_description": "Drug addiction is a major health issue still growing across the world including Pakistan. Associated physico-mental health issues, large direct health costs, negative social impact, and increasing death rates render drug addiction a global epidemic. Among addictive...",
        "meta_lang": "en",
        "meta_favicon": "/oscar-static/img/favicons/darwin/apple-touch-icon-92e819bf8a.png",
        "meta_site_name": "SpringerLink",
        "canonical_link": "https://link.springer.com/referenceworkentry/10.1007/978-3-030-67928-6_145-1",
        "text": "Ahmed B, Navid Yousaf F, Saud M et al (2020) Youth at risk: the alarming issue of drug addiction in academic institutions in Pakistan. Child Youth Serv Rev 118. 105385\n\nArias A, Feinn R, Kranzler HR (2006) Association of an Asn40Asp (A118G) polymorphism in the μ-opioid receptor gene with substance dependence: a meta-analysis. Drug Alcohol Depend 83:262–268\n\nBabbitt CC, Silverman JS, Haygood R et al (2010) Multiple functional variants in cis modulate PDYN expression. Mol Biol Evol 27:465–479\n\nBlum K, Badgaiyan RD, Dunston GM et al (2018) The DRD2 Taq1A A1 allele may magnify the risk of Alzheimer’s in aging African-Americans. Mol Neurobiol 55:5526–5536\n\nBurns JA, Kroll DS, Feldman DE et al (2019) Molecular imaging of opioid and dopamine systems: insights into the pharmacogenetics of opioid use disorders. Front Psych 10:626\n\nCheng C-Y, Hong C-J, Yu YW-Y et al (2005) Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Mol Brain Res 140:86–90\n\nClarke TK, Ambrose-Lanci L, Ferraro T et al (2012) Genetic association analyses of PDYN polymorphisms with heroin and cocaine addiction. Genes Brain Behav 11:415–423\n\nClarke TK, Weiss AR, Ferarro TN et al (2014) The dopamine receptor D2 (DRD2) SNP rs1076560 is associated with opioid addiction. Ann Hum Genet 78:33–39\n\nCrist RC, Clarke T-K, Berrettini WH (2018) Pharmacogenetics of opioid use disorder treatment. CNS Drugs 32:305–320\n\nDang LC, Samanez-Larkin GR, Castrellon JJ et al (2018) Individual differences in dopamine D2 receptor availability correlate with reward valuation. Cogn Affect Behav Neurosci 18:739–747\n\nDaumas S, Hunter CJ, Mistry RB et al (2017) The kinase function of MSK1 regulates BDNF signaling to CREB and basal synaptic transmission, but is not required for hippocampal long-term potentiation or spatial memory. Eneuro 4:e0212-16.2017 1–16\n\nDavis C, Levitan RD, Yilmaz Z et al (2012) Binge eating disorder and the dopamine D2 receptor: genotypes and sub-phenotypes. Prog Neuro-Psychopharmacol Biol Psychiatry 38:328–335\n\nDe Chiara V, Angelucci F, Rossi S et al (2010) Brain-derived neurotrophic factor controls cannabinoid CB1 receptor function in the striatum. J Neurosci 30:8127–8137\n\nDe Cid R, Fonseca F, Gratacòs M et al (2008) BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Genes Brain Behav 7:515–522\n\nDeak JD, Johnson EC (2021) Genetics of substance use disorders: a review. Psychol Med 51:2189–2200\n\nDoehring A, Von Hentig N, Graff J et al (2009) Genetic variants altering dopamine D2 receptor expression or function modulate the risk of opiate addiction and the dosage requirements of methadone substitution. Pharmacogenet Genomics 19:407–414\n\nEisenstein SA, Bogdan R, Love-Gregory L et al (2016) Prediction of striatal D2 receptor binding by DRD2/ANKK1 TaqIA allele status. Synapse 70:418–431\n\nEryilmaz IE, Erer S, Zarifoglu M et al (2020) Contribution of functional dopamine D2 and D3 receptor variants to motor and non-motor symptoms of early onset Parkinson’s disease. Clin Neurol Neurosurg 199:106257\n\nFillingim RB, Kaplan L, Staud R et al (2005) The A118G single nucleotide polymorphism of the μ-opioid receptor gene (OPRM1) is associated with pressure pain sensitivity in humans. J Pain 6:159–167\n\nForbes E, Brown SM, Kimak M et al (2009) Genetic variation in components of dopamine neurotransmission impacts ventral striatal reactivity associated with impulsivity. Mol Psychiatry 14:60–70\n\nFornasari D (2012) Pain mechanisms in patients with chronic pain. Clin Drug Investig 32:45–52\n\nFrank MJ, Hutchison K (2009) Genetic contributions to avoidance-based decisions: striatal D2 receptor polymorphisms. Neuroscience 164:131–140\n\nGao X, Wang Y, Lang M et al (2017) Contribution of genetic polymorphisms and haplotypes in DRD2, BDNF, and opioid receptors to heroin dependence and endophenotypes among the Han Chinese. Omics 21:404–412\n\nGerra G, Leonardi C, Cortese E et al (2007) Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction. Am J Med Genet B Neuropsychiatr Genet 144:771–775\n\nGlatt SJ, Bousman C, Wang RS et al (2007) Evaluation of OPRM1 variants in heroin dependence by family-based association testing and meta-analysis. Drug Alcohol Depend 90:159–165\n\nGOP (2017) Pakistan statistical year book 2017. Government of Pakistan, Islamabad\n\nGuillin O, Diaz J, Carroll P et al (2001) BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411:86–89\n\nGuindalini C, Howard M, Haddley K et al (2006) A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci 103:4552–4557\n\nHamidovic A, Dlugos A, Skol A et al (2009) Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp Clin Psychopharmacol 17:374\n\nHoehe MR, Köpke K, Wendel B et al (2000) Sequence variability and candidate gene analysis in complex disease: association of μ opioid receptor gene variation with substance dependence. Hum Mol Genet 9:2895–2908\n\nHong C-J, Cheng C-Y, Shu L-R et al (2003) Association study of the dopamine and serotonin transporter genetic polymorphisms and methamphetamine abuse in Chinese males. J Neural Transm 110:345–351\n\nIm D, Inoue A, Fujiwara T et al (2020) Structure of the dopamine D2 receptor in complex with the antipsychotic drug spiperone. Nat Commun 11:1–11\n\nJabeen S, Pinsonneault JK, Sadee W et al (2019) Significant association of DRD2 enhancer variant rs12364283 with heroin addiction in a Pakistani population. Ann Hum Genet 83:367–372\n\nJia W, Shi J, Wu B et al (2011) Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci Lett 495:221–224\n\nJones HE, Hairston E, Lensch AC et al (2021) Challenges and opportunities during the COVID-19 pandemic: treating patients for substance use disorders during the perinatal period. Prev Med 152:106742\n\nKoulousi A, Fidani L (2019) Tics and swearing: a review of recent genetic data concerning Tourette syndrome. Aristotle Biomed J 1:1–11\n\nKumar D, Chakraborty J, Das S (2012) Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population. Prog Neuro-Psychopharmacol Biol Psychiatry 36:225–230\n\nLevran O, Londono D, O’Hara K et al (2008) Genetic susceptibility to heroin addiction: a candidate gene association study. Genes Brain Behav 7:720–729\n\nLevran O, Londono D, O’Hara K et al (2009) Heroin addiction in African Americans: a hypothesis-driven association study. Genes Brain Behav 8:531–540\n\nLevran O, Peles E, Hamon S et al (2012) Nerve growth factor β polypeptide (NGFB) genetic variability: association with the methadone dose required for effective maintenance treatment. Pharmacogenomics J 12:319–327\n\nLohoff FW, Bloch PJ, Hodge R et al (2010) Association analysis between polymorphisms in the dopamine D2 receptor (DRD2) and dopamine transporter (DAT1) genes with cocaine dependence. Neurosci Lett 473:87–91\n\nMalik A, Sarfaraz SF (2011) Origin and development of drug addiction in South Asia with special reference to Pakistan. Pak J Commer Soc Sci 5:155–165\n\nMasiak J, Chmielowiec J, Chmielowiec K et al (2020) DRD4, DRD2, DAT1, and ANKK1 genes polymorphisms in patients with dual diagnosis of polysubstance addictions. J Clin Med 9:3593\n\nMerikangas KR, Stolar M, Stevens DE et al (1998) Familial transmission of substance use disorders. Arch Gen Psychiatry 55:973–979\n\nMichelhaugh SK, Fiskerstrand C, Lovejoy E et al (2001) The dopamine transporter gene (SLC6A3) variable number of tandem repeats domain enhances transcription in dopamine neurons. J Neurochem 79:1033–1038\n\nNida (2021) Heroin research report overview [Online]. Available: https://www.drugabuse.gov/publications/research-reports/heroin/overview. Accessed 15 July 2021\n\nOpris I, Hampson RE, Deadwyler SA (2009) The encoding of cocaine vs. natural rewards in the striatum of nonhuman primates: categories with different activations. Neuroscience 163:40–54\n\nPellegrini S, Palumbo S, Iofrida C et al (2017) Genetically-driven enhancement of dopaminergic transmission affects moral acceptability in females but not in males: a pilot study. Front Behav Neurosci 11:156\n\nPeng Q, Zhao J, Xue F (2010) A gene-based method for detecting gene-gene co-association in a case-control association study. Eur J Hum Genet 18:582–587\n\nPinsonneault JK, Han DD, Burdick KE et al (2011) Dopamine transporter gene variant affecting expression in human brain is associated with bipolar disorder. Neuropsychopharmacology 36:1644–1655\n\nPolimanti R, Walters RK, Johnson EC et al (2020) Leveraging genome-wide data to investigate differences between opioid use vs. opioid dependence in 41,176 individuals from the psychiatric genomics consortium. Mol Psychiatry 25:1673–1687\n\nRampino A, Marakhovskaia A, Soares-Silva T et al (2019) Antipsychotic drug responsiveness and dopamine receptor signaling; old players and new prospects. Front Psych 9:702\n\nRoberts SC, Berglas NF, Kimport K (2020) Complex situations: economic insecurity, mental health, and substance use among pregnant women who consider–but do not have–abortions. PLoS One 15:e0226004\n\nRouault M, Nielsen DA, Ho A et al (2011) Cell-specific effects of variants of the 68-base pair tandem repeat on prodynorphin gene promoter activity. Addict Biol 16:334–346\n\nRuzilawati AB, Islam MA, Muhamed SKS et al (2020) Smoking genes: a case–control study of dopamine transporter gene (SLC6A3) and dopamine receptor genes (DRD1, DRD2 and DRD3) polymorphisms and smoking behaviour in a Malay Male Cohort. Biomol Ther 10:1633\n\nSadee W, Hartmann K, Seweryn M et al (2014) Missing heritability of common diseases and treatments outside the protein-coding exome. Hum Genet 133:1199–1215\n\nSamochowiec J, Kucharska-Mazur J, Grzywacz A et al (2006) Family-based and case-control study of DRD2, DAT, 5HTT, COMT genes polymorphisms in alcohol dependence. Neurosci Lett 410:1–5\n\nShabalina SA, Zaykin DV, Gris P et al (2009) Expansion of the human μ-opioid receptor gene architecture: novel functional variants. Hum Mol Genet 18:1037–1051\n\nStoltenberg SF, Lehmann MK, Christ CC et al (2011) Associations among types of impulsivity, substance use problems and Neurexin-3 polymorphisms. Drug Alcohol Depend 119:e31–e38\n\nSullivan D, Pinsonneault J, Papp A et al (2013) Dopamine transporter DAT and receptor DRD2 variants affect risk of lethal cocaine abuse: a gene–gene–environment interaction. Transl Psychiatry 3:e222–e222\n\nUhl GR, Liu Q-R, Walther D et al (2001) Polysubstance abuse–vulnerability genes: genome scans for association, using 1,004 subjects and 1,494 single-nucleotide polymorphisms. Am J Hum Genet 69:1290–1300\n\nUNODC (2013) Drug use in Pakistan - technical summary report. Austria United Nations Office on Drug and Crime, Vienna\n\nUNODC (2021) The world drug report 2021. United Nations Office on Drugs and Crime, Vienna\n\nVolkow ND, Wise RA, Baler R (2017) The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 18:741–752\n\nWaller DG, Sampson A (2018) Medical pharmacology and therapeutics E-book. Elsevier Health Sciences\n\nWang S (2019) Historical review: opiate addiction and opioid receptors. Cell Transplant 28:233–238\n\nWei S, Zhu Y, Lai J et al (2011) Association between heroin dependence and prodynorphin gene polymorphisms. Brain Res Bull 85:238–242\n\nXuei X, Flury-Wetherill L, Bierut L et al (2007) The opioid system in alcohol and drug dependence: family-based association study. Am J Med Genet B Neuropsychiatr Genet 144:877–884\n\nYuferov V, Fussell D, Laforge KS et al (2004) Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction. Pharmacogenetics 14:793\n\nZhang Y, Wang D, Johnson AD et al (2005) Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280:32618–32624\n\nZhang H, Luo X, Kranzler HR et al (2006) Association between two μ-opioid receptor gene (OPRM1) haplotype blocks and drug or alcohol dependence. Hum Mol Genet 15:807–819\n\nZhang D, Shao C, Shao M et al (2007a) Effect of μ-opioid receptor gene polymorphisms on heroin-induced subjective responses in a Chinese population. Biol Psychiatry 61:1244–1251\n\nZhang Y, Bertolino A, Fazio L et al (2007b) Polymorphisms in human dopamine D2 receptor gene affect gene expression, splicing, and neuronal activity during working memory. Proc Natl Acad Sci U S A 104:20552–20557\n\nZhang J, Yan P, Li Y et al (2018) A 35.8 kilobases haplotype spanning ANKK1 and DRD2 is associated with heroin dependence in Han Chinese males. Brain Res 1688:54–64\n\nZhou H, Rentsch CT, Cheng Z et al (2020) Association of OPRM1 functional coding variant with opioid use disorder: a genome-wide association study. JAMA Psychiat 77:1072–1080"
    }
}